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ABSTRACT Thermally induced aggregates of a-chymotrypsinogen A and bovine granulocyte-colony stimulating factor in
acidic solutions were characterized by a combination of static and dynamic light scattering, spectroscopy, transmission electron
microscopy, and monomer loss kinetics. The resulting soluble, high-molecular weight aggregates (;103–105 kDa) are linear,
semiﬂexible polymer chains that do not appreciably associate with one another under the conditions at which they were formed,
with classic power-law scaling of the radius of gyration and hydrodynamic radius with weight-average molecular weight (Mw).
Aggregates in both systems are composed of nonnative monomers with elevated levels of b-sheet secondary structure, and
bind thioﬂavine T. In general, the aggregate size distributions showed low polydispersity by light scattering. Together with the
inverse scaling of Mw with protein concentration, the results clearly indicate that aggregation proceeds via nucleated (chain)
polymerization. For a-chymotrypsinogen A, the scaling behavior is combined with the kinetics of aggregation to deduce
separate values for the characteristic timescales for nucleation (tn) and growth (tg), as well as the stoichiometry of the nucleus
(x). The analysis illustrates a general procedure to noninvasively and quantitatively determine tn, tg, and x for soluble (chain
polymer) aggregates, as well as the relationship between tn/tg and aggregate Mw.
INTRODUCTION
Nonnative protein aggregation is a type of protein self-
assembly in which the resulting soluble or insoluble aggre-
gates are composed of monomers with secondary structures
that are signiﬁcantly altered from the native (monomer) state.
Nonnative protein aggregation is a common problem in
bioprocessing operations such as drying, reconstitution, and
storage (1). The presence of soluble aggregates in a protein
pharmaceutical may decrease its effectiveness or putatively
elicit an adverse immune response (2). Nonnative protein
aggregation has also been implicated in a variety of debili-
tating diseases such as Alzheimer’s and Huntington’s (3).
Recent evidence suggests that soluble aggregate precursors
rather than mature, insoluble ﬁbrils are the primary cytotoxic
species in a number of cases (4–6).
Common structural and morphological characteristics of
ﬁbril-forming systems are reasonably well established (7).
However, similarly detailed characterization and categoriza-
tion of aﬁbrillar or ‘‘amorphous’’ soluble and insoluble
aggregates are not typically reported (8,9). A small but
growing body of literature indicates that a range of aﬁbrillar
aggregate morphologies are possible (10,11). Interestingly,
unwanted aggregates in biotechnology applications are most
often broadly classiﬁed as amorphous or aﬁbrillar (1,12). A
more complete understanding of the underlying mechanism
and its relation to the resulting structure and morphology of
nonnative aggregates may ultimately suggest more effective
strategies for preventing or inhibiting their formation. From a
more fundamental perspective, nonnative aggregates present
an intriguing problem in understanding protein folding and
assembly in that they offer a potentially lower free energy
state than that of the folded monomer, provided that the total
protein concentration exceeds the theoretical threshold value
below which isolated monomers are thermodynamically
stable (13). Their formation can involve a complex set of
competing (mis)folding and assembly reactions that are dif-
ﬁcult to resolve directly via experiment (12,14–20), or to
access via molecular theory or simulation due to the long
time- and length-scales involved (21). Together, these obser-
vations suggest that an improved understanding of the
factors controlling the formation and properties of nonnative
aggregates without higher-order, supramolecular assembly
(e.g., before mature ﬁber assembly) would aid in both fun-
damental and applied research in this ﬁeld.
At a qualitative level, the overall or observed rate of
monomer loss or extent of conversion to aggregates can be
broadly categorized by the location of the slow step(s) in the
process. Unfolding-limited aggregation occurs when the
timescale for monomer unfolding greatly exceeds that for all
subsequent kinetic events, and is characterized by an
observed rate coefﬁcient that is independent of concentration
and comparable to that for unfolding (22–26). In the alter-
native, aggregation-limited case, the rate-determining steps
occur after the transition from folded to partially or com-
pletely unfolded monomer. Aggregation-limited cases can be
further classiﬁed in terms of the growth mechanism of the
aggregates (24,25). If the predominant growth route is
aggregate-aggregate association, or condensation, this gen-
erally leads to relatively low number concentrations of each
aggregate size and a wide distribution of sizes. If growth in-
stead occurs primarily by (chain) polymerization, the aggre-
gate size distribution is predicted to have lower polydispersity.
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The latter scenario is qualitatively implied in most models
of nucleated growth or nucleated polymerization (27–30).
Beyond these qualitative features, comparatively little has
been shown experimentally regarding general relationships
between kinetics and the morphology, structure, and size
distribution of the resulting aggregates before appreciable
condensation. For systems in which condensation steps are
appreciable throughout the aggregation process, a small
but increasing number of cases have been well described by
approaches that either include a priori knowledge of the mor-
phology of uncondensed and condensed aggregates (31–33),
or require the aggregates to condense to form insoluble, mac-
roscopic particles (34).
This report presents a detailed structural and morpholog-
ical characterization of thermally induced, soluble nonnative
aggregates of a-chymotrypsinogen A (aCgn) and bovine
granulocyte-colony stimulating factor (bG-CSF). Here struc-
ture refers to the characteristic dimensions and conforma-
tional state of the monomers within the aggregate, whereas
morphology refers to the spatial arrangement of these ele-
ments relative to each other in the aggregate as a whole.
Aggregates composed of monomers of similar structure may,
in principle, adopt dramatically different morphologies (e.g.,
linear chains, dendrimers, ﬁbrils) (35). The proteins inves-
tigated are model systems for the study of nonnative ag-
gregation relevant to biopharmaceutical stability (36–38),
product formulation (36,37,39), and mechanistic interpreta-
tion of the underlying kinetics (24,40). The results reported
here therefore offer an improved and more quantitative
picture for the underlying morphology of soluble aggregates
that potentially extends beyond aCgn and bG-CSF.
aCgn is a 25.7 kDa protein with pI ¼ 9.2 and mixed
a-helix/b-sheet secondary structure in its native and ther-
mally unfolded states, while bG-CSF is ;19 kDa with pI ¼
6.8 and essentially all a-helix in its native state. aCgn is the
inactive, zymogen precursor to the digestive enzyme chy-
motrypsin (41). bG-CSF is the bovine homolog to the
recombinant human G-CSF available as a commercial ther-
apeutic agent to ameliorate white blood cell loss during
chemotherapy (42). Both proteins are natively monomeric
and able to form nonnative, relatively high molecular weight
aggregates—i.e., the average number of monomers per
aggregate, or degree of polymerization, is of order 10 or
greater. Aggregation rates for both proteins are greatly accel-
erated at temperatures near and above their midpoint un-
folding temperatures (36,38,40). Despite being structurally
dissimilar monomers, the results here show that soluble
aggregates of each protein share common characteristics in
terms of morphology and structure that suggest similarities in
the mechanisms by which they form.
The structure of the aggregates at a protein chain level is
probed via circular dichroism (CD) spectroscopy and ﬂuo-
rescence upon thioﬂavine T (ThT) binding. These were se-
lected because for both ﬁbrillar and aﬁbrillar systems, CD
spectra of aggregates often display characteristic b-sheet
signals (14,15), while ThT binding and ﬂuorescence is often
considered to be indicative of ﬁbrillar, amyloid, and/or cross-
b-sheet structures and morphologies (43,44). For systems
that form ﬁbrils (i.e., condensed ﬁlaments), nonnative aggre-
gate structures are often high in b-sheet content, with long,
rigid-rod morphologies (45,46). The opposite extreme is that
of small, globular aggregates in which a reasonably con-
served b-sheet structure is less established (14,47).
The data are further analyzed within the context of nu-
cleated polymerization, utilizing a recently proposed math-
ematical model of nonnative aggregation kinetics (27). This
allows development of quantitative relationships between
the aggregate size and the number (x) of monomers in the
nucleus, the number (d) of monomers required to complete
a kinetic step during growth, and the ratio of characteristic
timescales for nucleation (tn) and growth (tg). Combining
these results with measurements of the kinetics of aggrega-
tion provides self-consistent estimates of tn and tg that can-
not otherwise be obtained without invasive approaches such
as seeding or chemical labeling (48,49), or by incorporating
a priori knowledge of the aggregate morphology (33).
MATERIALS AND METHODS
Solution preparation
aCgn (lyophilized powder, 63 crystallized, lot No. 105K7690) was pur-
chased from Sigma-Aldrich (St. Louis, MO) and used without further
puriﬁcation. bG-CSF (lyophilized powder) was donated by Pﬁzer Global
Research and Development (Bioprocess Research and Development,
Groton, CT) and used without further puriﬁcation (36–38). Stock solutions
of 10 mM citrate buffer were prepared by dissolving citric acid monohydrate
(Fisher Scientiﬁc, Pittsburgh, PA) in distilled, deionized water from a
Millipore (Billerica, MA) Milli-Q ﬁltration system with a Quantum EX
ultrapure Organex cartridge, and titrating to the desired pH with 5 M sodium
hydroxide solution (Fisher Scientiﬁc). aCgn samples at concentrations
between 0.5 and 8 mg/mL were gravimetrically prepared by dissolving
lyophilized powder in 10 mM citrate buffer (pH 3.5). bG-CSF samples at
concentrations between 0.5 and 1 mg/mL were gravimetrically prepared by
dissolving lyophilized powder in 10 mM citrate buffer (pH 3.0). The smaller
concentration range for bG-CSF was necessary to ensure that the aggre-
gation timescale remained within a reasonable range (;1–100 min) for the
purposes of this study. All concentrations were computed from purity spec-
iﬁcations based on UV extinction coefﬁcient measurements (36–38,40).
Aggregation was accelerated by thermostatting samples at 65C 6 0.2C
in a circulating water bath for a range of times (;3–400 min) previously
determined to yield a mass fraction of aggregates of 0.95 6 0.02. Samples
were quenched in an ice water bath immediately after each predetermined
hold time and refrigerated (2–8C) for a maximum of three days before use.
Subsequent measurements to characterize aggregate structure, size, and
morphology were performed at 20C unless otherwise noted.
Static light scattering (SLS) and dynamic light
scattering (DLS)
Light scattering ampules (1 mL) were purchased from Wheaton (Millsville,
NJ), triple-rinsed with distilled and deionized water and dried. SLS and DLS
data were acquired at 20C 6 0.2C using a Brookhaven (Holtsville, NY)
BI9000AT correlator and a BI200SM goniometer, and a Lexel (Fremont,
CA) model 95 argon ion laser operating at 488 nm. All light scattering
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measurements were performed at 20C 6 0.2C, with sample temperature
controlled by an external circulating bath.
The scattered intensity of samples containing protein aggregates was
recorded at 37 scattering angles between 30 and 120. The (isotropic)
scattered intensity of buffer solutions and a toluene reference were measured
over ﬁve angles between 88 and 92 and subsequently averaged. For se-
lected measurements, the average intensity measured over the entire angle
range from 30 to 120 was conﬁrmed to give identical values within in-
strument precision to that measured between 88 and 92. The excess
Rayleigh ratio was calculated as
Rex ¼ I  I0
Iref
 
n0
nref
 2
Rref ; (1)
where I is the scattered intensity of the sample, I0 is the averaged scattered
intensity of the buffer, Iref is the averaged scattered intensity of a toluene
standard, n0 is the refractive index of the buffer, nref is the refractive index of
toluene, and Rref is the Rayleigh ratio of toluene (39.6 3 10
6 cm1) (50).
The standard Zimm expression (51),
Kc
Rex
¼ PðuÞ1 1
Mw
1 2B22c
 
; (2)
relates the form factor, P(u), to the optical constant, K, the mass concen-
tration, c, the weight-average molecular weight,Mw, and the osmotic second
virial coefﬁcient, B22. The refractive index increment needed to calculate
K was taken to be 0.19 cm3/g at 20C, a value typical of small, globular
proteins (52). P(u) depends only on the geometry of the scattering object, and
is usefully written in the Guinier approximation as PðuÞ1 ¼ 11 q2R2g=3;
where Rg is the square-root of the z average of the square of the radius of
gyration (R2g ¼ +iciMiR2g;i=+iciMi; where R2g;i is the square of the radius of
gyration of an aggregate of size i) and q is the magnitude of the scattering
vector, q ¼ 4pn0 sin (u/2)/l0, where n0 is the refractive index of the solvent,
u is the scattering angle, and l0 is the wavelength of the light in vacuo.
Equation 2 can then be written as
Kc
Rex
¼ 1
Mw
1 2B22c
 
11
q
2
R
2
g
3
 !
: (3)
For a given aggregated sample with initial protein concentration c0,
different concentrations (c) were prepared gravimetrically by dilution with
buffer. Previous work established that dilution does not change the size or
structure of the protein aggregates, and was conﬁrmed for all samples here
by a lack of measurable change in aggregate size upon dilution (data not
shown). SLS data across all concentrations and angles were globally re-
gressed to Eq. 3 with a Levenberg-Marquardt nonlinear least-squares al-
gorithm using the lsqcurveﬁt function in MATLAB (The MathWorks, Natick,
MA) to obtain values and conﬁdence intervals for each of the three ﬁtted
parameters: Mw, B22, and Rg. To assess the robustness of the regression,
outliers were identiﬁed and excluded based on a two-tiered statistical test
(53,54). For a given data set, points with residuals that fell outside of two
standard deviations of the mean residual value from a ﬁt including all data
were identiﬁed as potential outliers. These points were excluded from a
second regression, and then compared to their predicted values from that
second regression. A potential outlier was subsequently rejected only if it fell
outside the 90% conﬁdence interval of the second regression. For all data
reported, the average percentage of points rejected as outliers was 3%, and
did not exceed 5% for any data set. Including or excluding outliers did not
change the values ofMw and Rg within statistical uncertainty, suggesting the
ﬁtted values of these parameters from global regression against Eq. 3 are
robust. Conversely, the large variability in ﬁtted B22 values and the weak
dependence of the scattered intensity on concentration precluded reliable
determination of B22 values. Speciﬁcally, the 95% conﬁdence intervals for
the ﬁtted B22 values were comparable to or larger than the magnitude of the
values themselves. This was attributed in part to the fact that the ﬁtted B22
values were invariably near zero (;105–106 mol mL g2).
For DLS measurements, all samples were diluted with buffer as needed to
nominally 0.2 mg/mL protein. The intensity autocorrelation function of each
sample was recorded at 20 angles between 25 and 120. The measured
intensity autocorrelation function was analyzed via an adaptation of the
method of cumulants (55,56), by nonlinear regression of G(2)(t) data as
G
ð2ÞðtÞ ¼ a1b expð2ÆGætÞ 11m2
2!
t
2
 2
; (4)
where a is an average baseline intensity, b is an instrument constant, ÆGæ is
the average decay constant (or ﬁrst cumulant), and m2 is the second moment
about the average decay constant. The reduced second moment, or poly-
dispersity index, deﬁned as
p2 ¼ m2ÆGæ2; (5)
is a dimensionless parameter that gives a direct measure of the width of the
underlying distribution of particle sizes (55,57). ÆGæ depends on q and can
be written as
ÆGæ ¼ q2D0ð11Cq2R2gÞ; (6)
where D0 is the z-average translational diffusion coefﬁcient (D0 ¼
+
i
ciMiD0;i=+iciMi; where D0,i is the translational diffusion coefﬁcient of
an aggregate of size i) and C is a numerical constant (58). D0 is related to the
effective hard-sphere hydrodynamic radius (Rh) via the Stokes-Einstein
equation (Rh ¼ kBT/6phD0, where kB is Boltzmann’s constant, T is the
thermodynamic temperature, and h is the viscosity of the solvent).
Size exclusion chromatography (SEC)
Monomer concentrations in protein samples were determined using either
an Agilent Technologies (Santa Clara, CA) HP1050 with a G1306A pho-
todiode array detector or a Waters (Milford, MA) Alliance 2695 separations
module with a 2996 photodiode array detector. Each instrument was equipped
with a Protein-Pak 7.8 3 300 mm size exclusion column maintained at
room temperature during the measurements. Sample injections of 100 mL
were eluted isocratically at 1 mL/min in a mobile phase composed of 0.5%
(v/v) phosphoric acid (Fisher Scientiﬁc) and distilled and deionized water
(pH adjusted to 2.5 with sodium hydroxide). Previous work established that
this mobile phase composition and pH minimize interactions with the
column and ensure consistent performance (36,40). All injected material was
recovered (conserved total integrated peak area), and all detectable aggre-
gates formed during incubation eluted in the void volume. For this column
the practical molecular weight cutoff is estimated to be 80 kDa (manufac-
turer speciﬁcation; J. Andrews, unpublished data). Peak areas recorded at
an absorption wavelength of 280 nm were converted to concentration
measurements by comparison with independently prepared calibration stan-
dards over the previously determined linear range of the assay (24,36).
Circular dichroism (CD)
Equilibrium, isothermal far-UV circular dichroism measurements were
made using a Jasco (Easton, MD) J-810 spectropolarimeter and a Jasco PTC-
424S Peltier temperature controller at 20C6 0.2C. Spectra were recorded
from 260 to 190 nm at a scanning rate of 20 nm/min in a 13 10 mm Hellma
(Plainview, NY) cuvette. Samples contained either native or fully
aggregated (mass fraction of aggregate ¼ 0.95 6 0.02) aCgn or bG-CSF
at 0.2 mg/mL. Seven spectra were recorded and averaged. The mean residue
ellipticity (½u deg cm2 dmol1) was calculated as ½u ¼ uM0=10c0dnr where
u is the average ellipticity in mdeg,M0 is the molecular weight of the protein
monomer in g/mol, c0 is the mass concentration of the protein in mg/mL, d is
the path length of the cuvette in cm, and nr is the number of amino-acid
residues in the monomer.
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Fluorescence spectroscopy and thioﬂavine T
(ThT) binding
A 7.78 mM stock solution was prepared by dissolving ThT (MP
Biomedicals, Solon, OH) in distilled, deionized water. Samples were
prepared for ﬂuorescence measurements by diluting the ThT stock solution
into aCgn and bG-CSF solutions to yield a 153molar excess of the dye over
the monomer. Equilibrium ﬂuorescence measurements were made using a
Jasco J-810 spectropolarimeter equipped with a FMO-427S ﬂuorescence
detector and a Jasco PTC-424S Peltier temperature controller at 20C 6
0.2C. Excitation and emission bandwidths were 10 nm. Emission spectra
were recorded at 20C in a 1 3 1 cm cuvette over a wavelength range of
460–600 nm (1 nm intervals) for an excitation wavelength of 450 nm. Seven
spectra were recorded and averaged for each sample.
Cryogenic transmission electron
microscopy (cryo-TEM)
Samples for cryo-TEM were examined using a Tecnai G2 12 TEM at an
acceleration voltage of 120 keV. Specimens were prepared using a Vitrobot
Mark II (FEI, Hillsboro, OR), a semiautomated preparation apparatus that
allows for computer-controlled blotting of grids in a temperature- and
humidity-controlled environment. Quantifoil grids (SPI Supplies, West
Chester, PA) were submerged in a liquid sample, blotted once for 1 s to
produce a thin liquid ﬁlm, allowed to relax for 20 s to eliminate shear-
induced artifacts, and then vitriﬁed by rapid immersion into liquid ethane
held at its freezing temperature. The temperature within the sample
preparation chamber was maintained at 25 6 0.5C and at least 95%
relative humidity. Vitriﬁed grids were transferred to a Gatan (Pleasanton,
CA) single tilt cryogenic holder cooled with liquid nitrogen. The temper-
ature of the grids was maintained below 170C during investigation in the
TEM. Digital images were recorded using a Gatan multiscan charge-coupled
device camera and processed with DigitalMicrograph software (Gatan).
RESULTS
Monomer loss kinetics
Monomer loss for a range of initial protein concentrations
was measured via SEC as a function of incubation time at
65C. The resulting kinetic proﬁles for aCgn were each ﬁt
using a nonlinear least-squares regression to the equation,
dm=dt ¼ kobsmd; where m ¼ c/c0, c is the monomer con-
centration, c0 is the initial monomer concentration, kobs is the
observed rate coefﬁcient ([¼]1/time), t is the incubation
time, and d is expected to be an integer (22). The data over all
c0 values are best ﬁt with d ¼ 1, although proﬁles with
d-values as high as 2 were also reasonable approximations
in some cases. The corresponding half-life value (t50), when
m¼ 0.5, is t50 ¼ lnð2Þk1obs: Equivalent values of t50 were also
obtained from visual interpolation of m versus t. Fig. 1 (main
panel) shows m versus t/t50 for aCgn with c0 ranging from
0.5 to 7.7 mg/mL. The values of log kobs versus log c0 are
shown in the inset to Fig. 1. They follow the scaling
relationship log kobs ¼ log k0 1 j log c0, with j ¼ 1.9 6 0.3
(95% conﬁdence interval) from linear regression, and
illustrate that kobs and t50 are strongly dependent on initial
protein concentration. Plotting on a t/t50 scale allows data
from a wide range of t50 values to be collapsed in a single
panel, and also illustrates that the data are reasonably
represented by a ﬁrst-order decay (dotted line in Fig. 1).
Monomer loss proﬁles for bG-CSF were qualitatively similar
to those for aCgn, but with a different range of t50 values.
Static and dynamic light scattering
Static and dynamic light scattering were used to characterize
each fully aggregated aCgn or bG-CSF sample. Samples
were considered fully aggregated when m ¼ 0.05 6 0.02, as
determined by SEC. Samples held at 65C for incubation
times that were a factor of two or greater than that needed to
reach m ¼ 0.05 were also tested and shown to give the same
results within statistical uncertainty (not shown). All samples
were optically transparent, without indications of precipita-
tion or visual particulate formation, even after prolonged
storage (.2 weeks) under refrigeration. Fig. 2 shows a
representative Zimm plot generated from SLS measurements
on a fully aggregated aCgn sample, c0 ¼ 0.7 mg/mL, with
dashed lines indicating the best ﬁt to Eq. 3. Qualitatively
similar results were observed for bG-CSF in all cases. Fitted
values and 95% conﬁdence intervals were obtained for Mw
and Rg; these values are presented and discussed further
below. As noted in Materials and Methods, the concentration
dependence of the scattered intensity was typically insufﬁ-
cient to determine values of B22 that were statistically
different from zero.
Fig. 3 shows representative examples of multi-angle DLS
data for aCgn for a single value of c0, and for different
FIGURE 1 (Main panel) Monomer fraction, (m), versus reduced time, (t/t50),
for aCgn as a function of initial protein concentration. c0/mg mL
1 ¼ 0.5
(open squares), 0.7 (solid triangles), 1.0 (open circles), 1.4 (solid diamonds),
2.0 (open triangles), 3.4 (solid squares), 4.8 (open diamonds), and 7.7 (solid
circles). Dotted and dashed lines represent purely ﬁrst order (d¼ 1) and purely
second order (d ¼ 2) decay, respectively. (Inset) Scaling of kobs with c0 for
aCgn. Solid line is a linear ﬁt to the data set on a log-log scale.
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scattering angles. The solid lines are best ﬁts to Eq. 4, and the
autocorrelation function for a native, monomeric sample
(20C, c0 ¼ 5 mg/mL) is shown for reference. Qualitatively
similar results were observed for bG-CSF in all cases. The
inset to Fig. 3 shows the ﬁtted values of ÆGæ for the aggregate
plotted as a function of q2. The solid line indicates a least-
squares ﬁt to Eq. 6 without assuming a zero y-intercept. The
value of C was calculated from the ﬁtted parameter R2gC
using the value of R2g from the corresponding SLS data.
Combining the ﬁtted value of D0 with the Stokes-Einstein
equation yielded Rh. The dashed line shows the limiting
slope of the solid line as q2 approaches zero, emphasizing the
deviation of ÆGæ from linearity at high q2. This behavior is
characteristic of a variety of molecular architectures,
including semiﬂexible polymer chains, provided that the
mobility of the internal domains is substantially different
from that of the center of mass (35,58,59).
The upper panel of Fig. 4 shows the scaling behavior of Rg
and Rh for both aCgn and bG-CSF aggregates as a function
of the c0 value of the initial, unaggregated sample. The solid
and dashed lines represent log-log ﬁts to the data. The lower
panel of Fig. 4 shows that values of the ratio r ¼ Rg/Rh
remain reasonably constant versus c0 for both aCgn and
bG-CSF aggregates. The upper panel of Fig. 5 shows the val-
ues of the polydispersity index (p2, Eq. 5) as a function of c0,
while the lower panel shows the corresponding C-parameter
values (Eq. 6). The p2 values indicate that the distribution of
aggregate sizes for both proteins is relatively narrow (57,60).
FIGURE 2 Representative Zimm plot generated from static light scatter-
ing measurements of aCgn aggregates showing experimental data points
(circles) and nonlinear least-squares ﬁt to Eq. 3 (dashed lines). Data shown
are for c0 ¼ 0.7 mg/mL. Outliers (3% of the points) are not shown.
FIGURE 3 (Main panel) Representative, normalized autocorrelation
function as a function of delay time and scattering angle for aCgn monomer
(90, c ¼ 5.0 mg/mL, squares) and aggregate (120, 55, 25, c0 ¼ 0.7 mg/
mL, circles). For clarity, every other autocorrelation data point is omitted
from each curve. All data are included in all analyses and ﬁtting. (Inset) ÆGæ
versus q2 for the aggregate data represented in the main panel (circles). The
solid line indicates a ﬁt to Eq. 6. The dashed line shows the limiting slope as
the scattering angle approaches zero.
FIGURE 4 (Top panel) Scaling of Rg (squares) and Rh (circles) with c0
for aCgn aggregates (open symbols) and bG-CSF aggregates (solid symbols).
The solid and dashed lines are linear ﬁts to the data on a log-log scale for
aggregates of aCgn and bG-CSF, respectively. (Bottom panel) r-ratio versus
c0 for aCgn aggregates (open diamonds) and bG-CSF aggregates (solid
diamonds).
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The r-values together with values of the C-parameter are con-
sistent with a semiﬂexible chain morphology (35,58,59,61).
Fig. 6 shows the scaling behavior of Rg and Rh with
respect to the reduced molecular weight (Mw/M0) of the
aggregates, where M0 is the molecular weight of the mono-
mer for aCgn (25.7 kDa) or bG-CSF (19 kDa). The solid and
dashed lines again represent log-log ﬁts. Fitted values of
Mw for different c0 ranged from ;1700–5600 kDa (;70–
220 M0) for aCgn aggregates, and ;4200–13,000 kDa
(;220–680 M0) for bG-CSF aggregates. The scaling expo-
nents (Rg}c
gc
0 ;Rh}c
hc
0 ;Rg}M
gm
w ;Rh}M
hm
w ) from the log-log
ﬁts in Figs. 4 and 6, average values of r from Fig. 4, and
95% conﬁdence intervals for each are given in Table 1.
Scaling exponents calculated from ﬁts to a power law rela-
tionship without ﬁrst converting to a log-log scale were the
same as those reported in Table 1 within statistical uncer-
tainty. Values of the scaling exponents gm and hm are also
consistent with a semiﬂexible, unbranched chain mor-
phology (35,62,63).
Cryo-TEM
Cryo-TEM measurements were performed on a series of
aCgn samples as a function of incubation time at 65C for
c0¼ 1.0 mg/mL. Representative images for fully monomeric
(m ¼ 1), partially aggregated (m ¼ 0.42 6 0.06) and fully
aggregated (m ¼ 0.05 6 0.02) samples are shown in Fig. 7,
A–C. The protein monomers (native state crystallographic
diameter;4 nm) (64) are too small to be quantiﬁed with this
technique. The mature, linear aCgn aggregates have an
apparent contour length of ;150–250 nm and apparent
width of;8–10 nm, without obvious branching. Aggregates
from other intermediate time points shared the same width
and qualitative shape as those in Fig. 7, B and C, consistent
with growth by linear polymerization. A representative
image from a similar measurement for a fully aggregated
bG-CSF sample (c0 ¼ 0.5 mg/mL) is shown in Fig. 7 D.
Aggregates of bG-CSF appear to have the same qualitative
morphology as those of aCgn, with a slightly greater width
(;10–13 nm) and much greater contour length (;200–800
nm). Crystallographically, native bG-CSF is roughly cylin-
drical with dimensions of; 2.53 4.5 nm (65). The lack of a
rigid-rod morphology was apparent in all cryo-TEM images.
Circular dichroism and ThT ﬂuorescence
The main panel of Fig. 8 shows the mean residue ellipticity
([u]) as a function of wavelength for both native and fully
aggregated samples of aCgn (c0 ¼ 1.0 mg/mL) and bG-CSF
(c0 ¼ 0.5 mg/mL). In both cases, the aggregate spectra are
indicative of an increased b-sheet structure, and this is dis-
tinct from both the native and unfolded monomers (37,40).
The inset of Fig. 8 shows the ﬂuorescence enhancement of
ThT in the presence of aCgn (c0 ¼ 1.0 mg/mL) and bG-CSF
(c0 ¼ 0.5 mg/mL) aggregates compared to that in a corre-
sponding solutions of only native monomers. Such increases
are similar to those typically reported for a variety of systems
that undergo nonnative aggregation (43,66).
DISCUSSION
Aggregate size, morphology, and polydispersity
It is important to establish whether appreciable aggregate
condensation or coalescence occurs during aggregate
FIGURE 5 (Top panel) p2 versus c0 for aggregates of aCgn (open squares)
and bG-CSF (solid squares) aggregates. (Bottom panel) C-parameter versus
c0 for aggregates of aCgn (open circles) and bG-CSF (solid circles).
FIGURE 6 Scaling of Rg (squares) and Rh (circles) with reduced Mw for
aggregates of aCgn (open symbols) and bG-CSF (solid symbols). The solid
and dashed lines are linear ﬁts on a log-log scale for the respective data sets.
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growth. For aggregates that remain soluble throughout the
course of assembly, all of the following experimental
signatures are expected if appreciable coalescence occurs:
Mw increases without a concomitant decrease in monomer
concentration, e.g., at long times once monomer concentra-
tion does not change appreciably; high polydispersity values
for the resulting aggregates (p2 values 0.3); and evidence
of higher order structure in microscopy, e.g., crosslinking,
bundling, or evidence that aggregates are composed of
distinct subunits that are themselves discernable aggregates.
Our light scattering and TEM data clearly show no evidence
of any of these experimental signatures for aCgn and bG-
CSF aggregates, and therefore indicate that the aggregates
are uncondensed. Additional details regarding the morphol-
ogy of the aggregates can be deduced from the analysis
below.
Values of the ratio r ¼ Rg/Rh correlate with the com-
pactness of the underlying polymer architecture, increasing
as the morphology becomes more open and extended and as
the polydispersity increases (35). The bottom panel of Fig. 5
shows that the values of r are reasonably independent of c0
for aggregates of both aCgn and bG-CSF, while Fig. 6 shows
the monotonic relationship for Rg(Mw) and Rh(Mw). To-
gether, these results indicate that the underlying morphology
is conserved across aggregates from these two proteins, even
though the resulting sizes are signiﬁcantly different. The
average values for r given in Table 1 are intermediate
between those for a theoretical Gaussian chain (r¼ 8/(3p1/2)
 1.505) (58) and a rigid rod (r . 2) (35). The values for p2
shown in the top panel of Fig. 5 indicate that the poly-
dispersity of the aggregated samples was relatively low
(average p2 ¼ 0.2). For comparison, a typical condensation
polymerization (Mw/Mn  2) with chains of similar ﬂexi-
bility would yield p2  0.3, while monodisperse chains
(Mw/Mn ¼ 1) would yield p2 ¼ 0 (57,60).
The value of the C-parameter is determined by the longest
internal mode of the polymer relative to its center of mass,
and is a measure of the ﬂexibility of the polymer molecular
architecture (35,58,59,61). The calculated values for aggre-
gates of aCgn and bG-CSF shown in the bottom panel of Fig.
5 lie between the values for a theoretical hard sphere (C ¼ 0)
(35) and a fully ﬂexible chain (C ; 0.2) (59). Values of the
scaling exponent gm for both aCgn aggregates and bG-CSF
aggregates (Table 1) lie between those for a Gaussian chain
(gm ¼ 0.5) and a rigid rod (gm ¼ 1) (35), and values of hm
also fall in the theoretical range for semiﬂexible chains (0.6
, hm , 1) (62,63). Together the light scattering data show
convincingly that soluble, nonnative aggregates of aCgn and
bG-CSF are each well described as linear, semiﬂexible
polymer chains with relatively low polydispersity.
The size and morphology of the aCgn and bG-CSF
aggregates indicated by light scattering measurements are
conﬁrmed by the cryo-TEM micrographs shown in Fig. 7.
The aggregates are linear chains without appreciable
branching or evidence of aggregate-aggregate condensation.
In keeping with this description, SLS measurements yield Rg
values of 63 6 2 nm and 117 6 2 nm for the aggregates of
aCgn and bG-CSF shown in panels C and D, respectively.
Upper estimates of the corresponding end-to-end distances
(Re) are ;150 nm and ;300 nm, respectively (based on the
Gaussian limit, R2g ¼ R2e=6) (67), which are also consistent
with the micrographs. The corresponding rigid rod limits for
the contour length (L) of aggregates with these Rg values are
;220 nm and ;400 nm for aCgn and bG-CSF, respectively
(R2g ¼ L2=12) (67). Caution must be exercised in extracting
length scales from cryo-TEM micrographs. As the images
are two-dimensional projections of a three-dimensional
sample, the degree to which aggregate chains protrude
above and below the image plane is difﬁcult to quantify.
Monomer structure in aggregates
The main panel of Fig. 8 indicates the secondary structure
changes upon aggregation for aCgn and bG-CSF. While both
proteins have appreciably different native secondary struc-
ture, their aggregate far-UV CD spectra are semiquantita-
tively similar. It is difﬁcult to reliably quantify or distinguish
different types of b-sheet structures using only far-UV CD.
However, for aCgn, the red shift compared to the unfolded
monomer spectra (40) along with the broad single minimum
near 212 nm are taken here to indicate a small but discernible
increase in b-sheet content. The data are insufﬁcient to draw
quantitative conclusions regarding the extent of b-sheet
conversion, or to assess whether a cross-b-sheet structure is
present. Doing so would presumably require techniques such
as infrared spectroscopy and/or x-ray diffraction. It should be
noted that structural analysis of model systems (68,69)
indicates that only relatively short series of amino acids
within a polypeptide chain are needed to stabilize nonnative
polymerization. For bG-CSF, the aggregate is conclusively
nonnative, but the CD spectrum is not sufﬁcient to conclude
that more than a small fraction of the residues in a given
monomer have adopted a b-sheet structure. Based on all of
the above considerations, a reasonable hypothesis is that the
TABLE 1 Summary of scaling exponents and average r-ratio values
gc hc Avg r-ratio gm hm
aCgn 0.3 6 0.1 0.27 6 0.07 1.65 6 0.1 0.74 6 0.16 0.64 6 0.12
bG-CSF 1.13 6 0.34 1.25 6 0.34 1.76 6 0.13 0.74 6 0.15 0.8 6 0.4
Deﬁnitions of the scaling exponents are provided in the text. The statistical uncertainties are 95% conﬁdence intervals.
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aggregates are composed of subunits in which only a fraction
of the amino acids from each (nonnative monomer) protein
chain have undergone large conformational rearrangements
to form stabilizing interprotein contacts.
Thioﬂavine T (ThT) binds to various types of b-sheet
architectures (44) and has been used as an indicator for the
presence of amyloid ﬁbrils (43). The approximately seven-
fold increase in the ﬂuorescence intensity maxima between
native and aggregated samples at comparable mass concen-
tration of protein (inset, Fig. 8) demonstrates speciﬁc binding
to the aggregates for both proteins. This is despite the rela-
tively small changes in CD spectra and the observation that
the aggregates do not form (amyloid) ﬁbrils or other higher-
order structures resulting from aggregate-aggregate conden-
sation under these conditions. This ﬁnding is consistent,
however, with previous work demonstrating ThT binding to
nonamyloid samples (44,70), and adds conﬁrmatory evi-
dence that ThT binding alone cannot be used to accurately
infer speciﬁc aggregate morphologies or underlying mono-
mer structure.
Scaling with c0 and relation to a
nucleated-growth mechanism
The observed scaling behavior of Mw with c0, and thus Rg
and Rh with c0, may at ﬁrst appear counterintuitive.
However, a recent model of nucleated polymerization (27)
naturally produces such behavior as a result of the different
dependencies of nucleation and growth rates on initial
protein concentration, and provides quantitative relation-
ships between this behavior and the relative stoichiometries
of nucleation and growth. Increasing c0 decreases the char-
acteristic timescales of both nucleation (tn) and growth (tg).
However, tn scales as c
1x
0 ; while tg scales as c
d
0 ; where
x denotes the number of monomers in the nucleus and d
denotes the number of monomers needed to advance poly-
mer growth by one kinetic step. When x . d 1 1, the
limiting Mw of the aggregates is predicted to decrease with
increasing c0 at ﬁxed temperature, pressure, and solvent
conditions (27). To the best of our knowledge, the results in
Fig. 4 are the ﬁrst experimental conﬁrmation of this be-
havior, and are analyzed further below using the LENP
model. The particular relationships of interest are (27)
tn

T;p;xi ;c0
¼ tð0Þn

T;p;xi
c0
cref
 1x
f
x
R

T;p;xi
; (7a)
tg

T;p;xi ;c0
¼ tð0Þg

T;p;xi
c0
cref
 d
f dR

T;p;xi
; (7b)
FIGURE 7 Cryo-TEM micrographs of aCgn samples (c0 ¼ 1 mg/mL) at
m ¼ 1 (A), m ¼ 0.42 6 0.06 (B), and m ¼ 0.05 6 0.02 (C) and a bG-CSF
sample (c0 ¼ 0.5 mg/mL) at m ¼ 0.05 6 0.02 (D). The white arrows in
panels A and B indicate artifacts caused by crystallization of water vapor on
the grid. The black arrows indicate sections of the main image that appear
as insets for greater clarity. Main panel scale bar: 200 nm. (Inset scale bar)
50 nm.
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where t
ð0Þ
n ; t
ð0Þ
g ; and fR are, respectively, the intrinsic
nucleation timescale, intrinsic growth timescale, and fraction
of monomeric protein that exists in the reactive (unfolded)
conformational state. Each of these parameters is indepen-
dent of c0, and constant for a given protein at ﬁxed tem-
perature, pressure, and solvent composition (T, p, and xi)
(27), such as the conditions for all data reported here. cref is
an arbitrary, ﬁxed reference concentration that sets the values
of t
ð0Þ
g and t
ð0Þ
n : kobs from monomer loss kinetics or any
extent-of-reaction based kinetics is given by (27)
kobs ¼ k1ðtntgÞ1=2
;
c0
cref
 ðx1d1Þ=2
; (8)
where k1 is a constant of order one that depends weakly on
x and d, and is otherwise independent of c0. In addition, the
Mw of the soluble aggregates as m goes to zero is given by
Mw
M0
 2
m/0
¼ k2 tn
tg
 
;
c0
cref
 ð11dxÞ
; (9)
where k2 is again a constant of order one that depends
weakly on x and d, and is independent of c0. M0 is the
molecular weight of the monomer, and the subscript m/0
indicates the quantity is evaluated as the mass fraction of
remaining monomer approaches zero. Combining Eqs. 8 and
9 and neglecting the weak and c0-independent contributions
of k1 and k2 gives
tn ¼ ðMw=M0Þm/0
kobs
; (10a)
tg ¼ 1
kobsðMw=M0Þm/0
: (10b)
Equations 8–10 hold for conditions in which (Mw/M0)m/0
. ;10 (27).
Fig. 9 shows tn and tg calculated from Eq. 10 and the
experimental kobs andMw data over a range of c0 for aCgn. If
the nucleated polymerization model accurately represents the
experimental data, tn and tg should scale with c0 according
to Eq. 7, and the resulting x and d values should be the same
as those derived from the m(t/t50) proﬁles and the scaling of
kobs with c0 (27,40). The slopes for tn and tg versus c0 in Fig.
9 are 2.4 6 0.4 and 1.5 6 0.3, respectively (95%
conﬁdence intervals). Using experimental values of kobs or
t50 without assuming d ¼ 1 when ﬁtting monomer loss data
(e.g., using d ¼ 2) makes minor, c0-independent changes in
the absolute values of tn and tg that are imperceptible on the
log scale in Fig. 9. The slope of tn in Fig. 9 indicates a
nucleus size (x) of 3–4 monomers, suggesting both trimers
and tetramers act effectively as nuclei. This is consistent with
a previous analysis based purely on the scaling behavior of
kobs with c0, and the observation that at higher temperatures
(75–80C) a competition between two nucleus sizes is
clearly evident (40). Unlike that previous analysis, the results
for x and d from the c0 scaling in Fig. 9 do not rely upon
inferring a value of d from m versus t. Furthermore, the
analysis above provides separate values of tn and tg, while
extent-of-reaction or monomer-loss data alone cannot pro-
vide more than the product of tn and tg (27,40). In addition,
Eq. 9 provides a simple and useful relationship in that it
shows the limiting value of Mw provides a quantitative
estimate of the ratio of nucleation to growth timescales. For
FIGURE 8 (Main panel) Far-UV CD spectra of aCgn monomer (solid
gray line) and aggregate (dashed gray line), and bG-CSF monomer (solid
black line) and aggregate (dashed black line) at 20C 6 0.2C. (Inset)
Fluorescence emission spectra of ThT in the presence of aCgn monomer
(solid gray line) and aggregate (dashed gray line), and bG-CSF monomer
(solid black line) and aggregate (dashed black line) at 20C 6 0.2C.
FIGURE 9 Rate diagram for aCgn with nucleation (squares) and growth
(circles) timescales as a function of c0. The solid lines are linear ﬁts to the
data on a log-log scale.
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aCgn, the observed range of limiting Mw/M0 values (;70–
220) thus correspond to values of tn/tg ; 5 3 10
3 to 5 3
104, consistent with the vertical distance between the tn and
tg curves in Fig. 9. A similar analysis to that above can be
performed for bG-CSF, but is not included here. The much
larger variability found for kobs values, and the much smaller
c0 range over which they were measurable at 65C presently
preclude an accurate assessment of tn, tg, x, and d. Equation
9 can still be applied, however, as it does not require accurate
kobs values. Doing so yields tn/tg values of order 10
4–105,
consistent with the larger aggregate sizes for bG-CSF
compared to aCgn, as observed in Figs. 4, 6, and 7.
The results in Fig. 9 are particularly important in that they
illustrate a general procedure for extracting distinct values of
tn and tg for a given T, p, xi, c0, and protein of interest
without the need for indirect experiments such as seeding
and chemical labeling. Unlike previous approaches and
models of nonnative aggregation in which nucleation and
growth timescales were regressed from experimental kinetic
and/or light scattering data (33,71,72), the above analysis is
independent of the particular morphology of the aggregates,
and it does not require one to impose a priori assumptions
regarding tn/tg (73–75). That is, although the morphology
and the relationship between Rg, Rh, and Mw have been
determined in this report, this information is not needed to
perform the timescale analysis described above, provided
that the aggregates have not condensed appreciably before
the monomer supply has been signiﬁcantly depleted. If
aggregate condensation is the predominant growth mecha-
nism, then accurate information regarding morphology is
required to employ light scattering to extract meaningful
kinetic parameters (31,33,72). In either case, imposing
assumptions regarding tn/tg will artiﬁcially constrain the
predicted size distribution and the ability of the model to
describe the light scattering data (27).
Eq. 7 shows that tn and tg are both functions of c0 and the
free energy of unfolding of the monomer (via fR). These
contributions can be factored out using experimental values
for protein concentration and unfolding free energy
(24,38,40). The resulting intrinsic timescales for nucleation
and growth are then of further value in that they provide
quantitative bounds on interpretations of the effects of pro-
tein sequence, charge, and sample conditions on factors such
as prenuclei free energies and the rate-controlling step(s) for
nucleation and growth (27,40).
In the simplest version of the nucleated growth model, x
and d are assumed to have integer values. The observation
that intermediate values are obtained suggests that both
nucleation and growth may more accurately be described as
occurring via two competing species at this temperature, and
solvent conditions, nucleation from both trimers and tetra-
mers, and growth via addition of one to two monomers. The
estimated width of the aggregates from cryo-TEM, ;10 nm
(approximately twice the diameter of the monomer), lends
additional support to a qualitative mechanism in which each
growth step during polymerization requires one or two
monomers to progress to the next stable polymer length. In
general, the value of d is not necessarily the number of
monomers in a cross-section of the aggregate chains. It is
simply the number of monomers that must reversibly as-
sociate with a previously formed aggregate before the mono-
mers forming the necessary stabilizing interprotein contacts
to commit them (irreversibly) to that aggregate (27).
CONCLUSIONS
Thermally induced, nonnative aggregates of aCgn and bG-
CSF were characterized using a combination of light
scattering, spectroscopy, and microscopy. The combined
results unambiguously indicate that the aggregates from both
systems are linear, semiﬂexible polymer chains with rela-
tively low polydispersity, and increased nonnative b-sheet
secondary structure. The aggregates bind thioﬂavine T,
without evidence for the formation of (amyloid) ﬁbrils or
higher-order structures resulting from association or con-
densation. Distinct values for the nucleation and growth
timescales were calculated without the need for seeding or
addition of chemical labels, or assumptions about the
underlying structure and morphology of the aggregates.
These timescales scale differently with initial protein con-
centration and provide a self-consistent explanation for the
experimental observation that relatively few, large aggre-
gates are formed at low c0, and a greater number of smaller
aggregates are formed at high c0. Although suggested by
recent theoretical work (27), to the best of our knowledge
this is the ﬁrst time such qualitative and quantitative scaling
behavior and timescale analysis has been shown experimen-
tally for aggregated proteins. In total, the t50-Mw method
presented here produces scaling behavior and ﬁtted stoichi-
ometries for nucleation and growth that agree well with those
of an alternative approach based exclusively on monomer
loss kinetics (40), and has the added beneﬁt of being able to
separate the nucleation and growth timescales when aggre-
gate condensation is not appreciable. This, and its more
general form in which aggregate Mw and monomer loss are
coupled as a function of time (27), offer a potentially
powerful and widely applicable approach for determining
key mechanistic parameters of protein nucleation and growth
before subsequent condensation.
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